Idexx Laboratories (IDXX) Cash from Operations Growth (1y) (2010 - 2026)
Idexx Laboratories (IDXX) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | 51.89% |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | 14.65% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 86.90% |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | 25.34% |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | 25.96% |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | -9.63% |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | -14.10% |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | 31.33% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 9.74% |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn | 935.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 86.90% |
| Mar 31, 2026 | 11.89% |
| Dec 31, 2025 | 35.77% |
| Sep 30, 2025 | 82.82% |
| Jun 30, 2025 | -25.20% |
| Mar 31, 2025 | 19.83% |
| Dec 31, 2024 | 4.87% |
| Sep 30, 2024 | -19.22% |
| Jun 30, 2024 | 23.96% |
| Mar 31, 2024 | 7.98% |
| Dec 31, 2023 | 44.07% |
| Sep 30, 2023 | 44.14% |
| Jun 30, 2023 | 204.20% |
| Mar 31, 2023 | 60.33% |
| Dec 31, 2022 | -17.40% |
| Sep 30, 2022 | 0.96% |
| Jun 30, 2022 | -71.85% |
| Mar 31, 2022 | -7.81% |
| Dec 31, 2021 | -4.10% |
| Sep 30, 2021 | -3.06% |